FIIs acquire over 1.2 million shares in Sequent Scientific

Several foreign institutional investors acquired over 1.2 million shares in the pharmaceutical and speciality chemicals firm -- Sequent Scientific.

Route One Fund 1 LP has acquired 400,000 shares, Morgan Stanley Asia (Singapore) PTE acquired 408,743 shares and Merrill Lynch Capital Markets Espana SA SV acquired 400,000 shares in the company. The shares were acquired at Rs 250 each.

Meanwhile, Primera Partners PTE has sold 1.29 million shares of Sequent Scientific.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.